Gan J - Search Results

1

Alteration of the CD34+ Tf-1 beta cell line profile in response to long-term exposure to IL-15.

Farner NL, Gan J, de Jong JL, Leary TP, Fenske TS, Buckley P, Dunlap S, Sondel PM. Farner NL, et al. Among authors: gan j. Cytokine. 1997 May;9(5):316-27. doi: 10.1006/cyto.1996.0171. Cytokine. 1997. PMID: 9195130

2

Distinction between gamma c detection and function in YT lymphoid cells and in the granulocyte-macrophage colony-stimulating factor-responsive human myeloid cell line, Tf-1.

Farner NL, Voss SD, Leary TP, Gan J, Hakimi J, Evans G, Ju G, Sondel PM. Farner NL, et al. Among authors: gan j. Blood. 1995 Dec 15;86(12):4568-78. Blood. 1995. PMID: 8541547 Free article.

3

Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.

Helfand SC, Hank JA, Gan J, Sondel PM. Helfand SC, et al. Among authors: gan j. Cell Immunol. 1996 Jan 10;167(1):99-107. doi: 10.1006/cimm.1996.0012. Cell Immunol. 1996. PMID: 8548851

4

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma.

Mahvi DM, Sondel PM, Yang NS, Albertini MR, Schiller JH, Hank J, Heiner J, Gan J, Swain W, Logrono R. Mahvi DM, et al. Among authors: gan j. Hum Gene Ther. 1997 May 1;8(7):875-91. doi: 10.1089/hum.1997.8.7-875. Hum Gene Ther. 1997. PMID: 9143914

5

Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).

Hank JA, Surfus JE, Gan J, Jaeger P, Gillies SD, Reisfeld RA, Sondel PM. Hank JA, et al. Among authors: gan j. Clin Cancer Res. 1996 Dec;2(12):1951-9. Clin Cancer Res. 1996. PMID: 9816154

6

Distinct clinical and laboratory activity of two recombinant interleukin-2 preparations.

Hank JA, Surfus J, Gan J, Albertini M, Lindstrom M, Schiller JH, Hotton KM, Khorsand M, Sondel PM. Hank JA, et al. Among authors: gan j. Clin Cancer Res. 1999 Feb;5(2):281-9. Clin Cancer Res. 1999. PMID: 10037176 Clinical Trial.

7

Specific enzyme-linked immunosorbent assays for quantitation of antibody-cytokine fusion proteins.

Gan J, Kendra K, Ricci M, Hank JA, Gillies SD, Sondel PM. Gan J, et al. Clin Diagn Lab Immunol. 1999 Mar;6(2):236-42. doi: 10.1128/CDLI.6.2.236-242.1999. Clin Diagn Lab Immunol. 1999. PMID: 10066660 Free PMC article.

8

Expression of a tumor-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery.

Nicolet CM, Burkholder JK, Gan J, Culp J, Kashmiri SV, Schlom J, Yang NS, Sondel PM. Nicolet CM, et al. Among authors: gan j. Cancer Gene Ther. 1995 Sep;2(3):161-70. Cancer Gene Ther. 1995. PMID: 8528959

9

Preclinical and clinical development of immunocytokines.

Sondel PM, Hank JA, Gan J, Neal Z, Albertini MR. Sondel PM, et al. Among authors: gan j. Curr Opin Investig Drugs. 2003 Jun;4(6):696-700. Curr Opin Investig Drugs. 2003. PMID: 12901228 Review.

10

Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma.

Choi BS, Sondel PM, Hank JA, Schalch H, Gan J, King DM, Kendra K, Mahvi D, Lee LY, Kim K, Albertini MR. Choi BS, et al. Among authors: gan j. Cancer Immunol Immunother. 2006 Jul;55(7):761-74. doi: 10.1007/s00262-005-0069-7. Epub 2005 Sep 27. Cancer Immunol Immunother. 2006. PMID: 16187086 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,198 results

Search Page

Filters